Showing results (41-50 of 60) with videos related to
Sort By:
Pageof 6
Cell Reports. Medicine|March 2, 2022
Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infectionEdwards Pradenas, Benjamin Trinité, Víctor Urrea, et al.Life Science Alliance|August 12, 2022
Efficacy of SARS-CoV-2 vaccination in patients with monoclonal gammopathies: A cross sectional studyEugenia Abella, Macedonia Trigueros, Edwards Pradenas, et al.Age and Ageing|May 20, 2022
Reduced humoral response 3 months following BNT162b2 vaccination in SARS-CoV-2 uninfected residents of long-term care facilitiesMacedonia Trigueros, Edwards Pradenas, Dolors Palacín, et al.Journal of Translational Medicine|January 4, 2024
Virus-like particle-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in miceAna Barajas, Pep Amengual-Rigo, Anna Pons-Grífols, et al.Viruses|July 2, 2021
Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated IndividualsBenjamin Trinité, Edwards Pradenas, Silvia Marfil, et al.Med (New York, N.Y.)|February 8, 2021
Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodesEdwards Pradenas, Benjamin Trinité, Víctor Urrea, et al.NPJ Vaccines|April 6, 2023
An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responsesFerran Tarrés-Freixas, Carmen Aguilar-Gurrieri, María Luisa Rodríguez de la Concepción, et al.NPJ Vaccines|February 27, 2024
Immunisation efficacy of a stabilised SARS-CoV-2 spike glycoprotein in two geriatric animal modelsCarla Usai, Erola Ainsua-Enrich, Victor Urrea Gales, et al.Scientific Reports|January 29, 2021
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severityBenjamin Trinité, Ferran Tarrés-Freixas, Jordi Rodon, et al.Nature Communications|February 5, 2024
A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activityLeire de Campos-Mata, Benjamin Trinité, Andrea Modrego, et al.Pageof 6